Anemia Treatment Injection Franchise in Ahmedabad

Darbepoetin Alfa Injection Supplier in Mumbai

CKD Anemia Injection Distributor in Delhi

Renal Care Injection Manufacturer in Bangalore

Hematology Injection Stockist in Hyderabad
Darbepoetin Injection Exporter in Chandigarh

Home/Products /darbepoetin-alfa-25mcg-injection

Darbot 25 injection

Composition : Darbepoetin alfa (25mcg) Injection

Dosage Form : Injection

Packaging Type : Pre-Filled Syringe

Packaging : 25mcg

Price : ₹1/-

Please Contact For Best Price

Darbepoetin Alfa 25mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce more red blood cells, helping improve hemoglobin levels and oxygen-carrying capacity in patients suffering from anemia.

This injection is widely prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia treatment, supporting improved energy levels and overall patient well-being.

With strong clinical relevance in nephrology and oncology care, high hospital demand, and essential role in anemia management protocols, this formulation strengthens institutional therapy portfolios and supports consistent therapeutic utilization.

Read More

About the Product

Darbepoetin Alfa 25mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce more red blood cells, helping improve hemoglobin levels and oxygen-carrying capacity in patients suffering from anemia.

This injection is widely prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia treatment, supporting improved energy levels and overall patient well-being.

With strong clinical relevance in nephrology and oncology care, high hospital demand, and essential role in anemia management protocols, this formulation strengthens institutional therapy portfolios and supports consistent therapeutic utilization.

Some patients may experience increased blood pressure, headache, injection site discomfort, nausea, or fatigue. In rare cases, allergic reactions, blood clots, or severe hypertension may occur and require immediate medical attention.

Darbot 25 Injection is indicated for the treatment of anemia associated with chronic kidney disease, including patients undergoing dialysis and those not on dialysis. It is also used to manage anemia in patients receiving chemotherapy for certain types of cancer.

This injection should be administered under the supervision of a qualified healthcare professional. Regular monitoring of hemoglobin levels and blood pressure is recommended during treatment. The dosage should be adjusted based on the patient’s clinical response and medical advice.

Store in a refrigerator at 2°C–8°C. Do not freeze. Protect from light and keep the injection in its original packaging. Keep out of reach of children.

Get in Touch